Letrozole Tablet, Film Coated
Product Images NDC 63629-7819

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 63629-7819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636297819)

This is a description for Letrozole 2.5mg, a yellow round tablet packaged by Bryant Ranch Prepack Burkbank. It has an NDC of 6362978191 and an expiration date of MM/YY. It is recommended to be stored at room temperature (20°-25°C or 68°-77°F) and kept out of reach of children. This medication is comparable to Femara 2.5mg Tablet and is sold in a package of 30 tablets.*

FDA Label Image

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Fig1)

FDA Label Image

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Fig2)

FDA Label Image

Figure 3 Survival By Randomized Treatment Arm (Letrozole Fig3)

FDA Label Image

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Fig4)

FDA Label Image

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Fig5)

FDA Label Image

Letrozole Structural Formula (Letrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.